SCHEMBL17786242

SCHEMBL17786242

Cn1c(=O)c2c(ncn2CCc2ccccc2)n(C)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 1.00
TSHR P16473 1/20 0.85
CNOT7 Q9UIV1 4/20 0.79
ADORA2B P29275 7/20 0.78
SMN1; SMN2 Q16637 2/20 0.78
RXFP1 Q9HBX9 1/20 0.78
POLB P06746 1/20 0.69
HIF1A Q16665 1/20 0.69
LMNA P02545 2/20 0.63
MAPT P10636 1/20 0.63
GLA P06280 1/20 0.60
HTT P42858 1/20 0.60
UBE2N P61088 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
MAPK1 P28482 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15012556 0.87 ALDH1A1 (0.77) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
SCHEMBL1944405 0.87 ADORA2B (1.00) ALDH1A1TSHRADORA2BSMN1; SMN2RXFP1
SCHEMBL27583105 0.87 CNOT7 (0.78) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
SCHEMBL28752095 0.86 ALDH1A1 (0.75) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
SCHEMBL11884633 0.85 TSHR (0.78) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
SCHEMBL28749916 0.85 ALDH1A1 (0.73) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
SCHEMBL27600305 0.85 ALDH1A1 (0.73) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
SCHEMBL10895834 0.84 TSHR (0.72) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
SCHEMBL27600238 0.84 ALDH1A1 (0.72) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2
Methane SCHEMBL27600242 0.84 ALDH1A1 (0.72) ALDH1A1TSHRCNOT7ADORA2BSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016086008-A1 SMALL MOLECULE ALDEHYDE DEHYDROGENASE INHIBITORS AND METHODS OF USE THEREOF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2016-06-02 WO disclosed